H. influenzae is a highly contagious human pathogen. It is a normal commensal of the upper respiratory tract, but can cause invasive disease including septicemia, pneumonia, and meningitis.
| Inventor | Institute |
|---|---|
| Michael Apicella | The University of Iowa |
| Cat. #: | 153704 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Immunology;Microbiology |
| Target: | LPS epitope, TEPC-15 |
| Reactivity: | Haemophilus influenzae |
| Clone: | 12D9 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | H. influenzae is a highly contagious human pathogen. It is a normal commensal of the upper respiratory tract, but can cause invasive disease including septicemia, pneumonia, and meningitis. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG3 + G1&G2a reaction |
| Target background: | H. influenzae is a highly contagious human pathogen. It is a normal commensal of the upper respiratory tract, but can cause invasive disease including septicemia, pneumonia, and meningitis. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.